| Structure | Chemical Name | CAS | MF |
|
FMOC-T-BUTYL-L-ALANINE
|
139551-74-9
|
C22H25NO4
|
|
Fmoc-Leu-Ome
|
139551-80-7
|
C22H25NO4
|
|
FMOC-L-LEUCINOL
|
139551-83-0
|
C21H25NO3
|
|
1,3-Dioxolane,2-bromo-(9CI)
|
139552-12-8
|
C3H5BrO2
|
|
2-Pyridinecarboxylicacid,6-amino-2,3-dihydro-,(-)-(9CI)
|
139552-67-3
|
C6H8N2O2
|
|
resorstatin
|
139552-96-8
|
C17H28O2
|
|
cyclooctatin
|
139552-97-9
|
C20H34O3
|
|
4-Bromo-2-methyl-1,3-benzenediol
|
139553-46-1
|
C7H7BrO2
|
|
DNP-PRO-GLU-ALA-ASN-NH2
|
139554-33-9
|
C23H30N8O11
|
|
N-BIOTINYL-N'-MALEIMIDO-ETHYLENEDIAMINE
|
139554-72-6
|
C16H22N4O4S
|
|
1,3,5-Triazine-2,4-diamine,6-methoxy-,3-oxide(9CI)
|
139554-84-0
|
C4H7N5O2
|
|
t-butyloxycarbonyl-cyclo(cysteinyl-t-butylseryl-asparaginyl-leucyl-t-butylseryl-t-butylthreonyl-cysteinyl)-valyl-leucyl-glycine
|
139555-60-5
|
C56H99N11O17S2
|
|
1-CHLORO-2,3-DIHYDRO-2,2-DIMETHYL-5-METHOXY-1H-INDENE
|
139557-24-7
|
C12H15ClO
|
|
1-CHLORO-2,3-DIHYDRO-2,2,5-TRIMETHYL-1H-INDENE
|
139557-27-0
|
C12H15Cl
|
|
1-CHLORO-2,3-DIHYDRO-2,2,6-TRIMETHYL-1H-INDENE
|
139557-28-1
|
C12H15Cl
|
|
5-BROMO-1-CHLORO-2,3-DIHYDRO-2,2-DIMETHYL-1H-INDENE
|
139557-29-2
|
C11H12BrCl
|
|
6-BROMO-1-CHLORO-2,3-DIHYDRO-2,2-DIMETHYL-1H-INDENE
|
139557-30-5
|
C11H12BrCl
|
|
1,6-DICHLORO-2,3-DIHYDRO-2,2-DIMETHYL-1H-INDENE
|
139557-31-6
|
C11H12Cl2
|
|
6-bromobenzo[c]isoxazole
|
139557-44-1
|
C7H4BrNO
|
|
2-(4-[4-(DIMETHYLAMINO)PHENYL]-1,3-BUTADIENYL)-1-METHYLPYRIDINIUM IODIDE
|
139557-65-6
|
C18H21IN2
|
|
3(2H)-Isoquinolinimine(9CI)
|
139557-81-6
|
C9H8N2
|
|
BOC-DL-2'-METHYLPHENYLALANINE, 98
|
139558-50-2
|
C15H21NO4
|
|
2-[(TERT-BUTOXY)CARBONYLAMINO]-3-(2,6-DIMETHYLPHENYL)PROPANOIC ACID
|
139558-51-3
|
C16H23NO4
|
|
cyclohexyl cysteinate
|
139560-16-0
|
C9H17NO2S
|
|
Cyclopropanecarboxylic acid, 1-amino-2-(3-hydroxyphenyl)-, (1R-trans)- (9CI)
|
139561-05-0
|
C10H11NO3
|
|
Cyclopropanecarboxylic acid, 1-amino-2-(3-hydroxyphenyl)-, (1S-trans)- (9CI)
|
139561-06-1
|
C10H11NO3
|
|
Cyclopropanecarboxylic acid, 1-amino-2-(3-hydroxyphenyl)-, (1R-cis)- (9CI)
|
139561-07-2
|
C10H11NO3
|
|
Cyclopropanecarboxylic acid, 1-amino-2-(3-hydroxyphenyl)-, (1S-cis)- (9CI)
|
139561-08-3
|
C10H11NO3
|
|
Cyclobutanecarboxylic acid, 2-(1-methylethenyl)-, methyl ester, (1S-cis)- (9CI)
|
139561-15-2
|
C9H14O2
|
|
Cyclobutanecarboxylic acid, 2-(1-methylethenyl)-, methyl ester, (1R-trans)-
|
139561-17-4
|
C9H14O2
|
|
Cyclobutanecarboxylic acid, 1-methyl-2-(1-methylethenyl)-, (1S-cis)- (9CI)
|
139561-18-5
|
C9H14O2
|
|
Cyclobutanecarboxylic acid, 1-methyl-2-(1-methylethenyl)-, (1R-trans)- (9CI)
|
139561-19-6
|
C9H14O2
|
|
Epicannabidiol hydrate
|
139561-95-8
|
C21H32O3
|
|
1,2-dihydroxy-5,6-dimethyl-3,4-epoxy-1,2,3,4-tetrahydrochrysene
|
139562-15-5
|
C20H18O3
|
|
hatomarubigin A
|
139562-86-0
|
|
|
Bis[1-(2-chlorophenyl)-2-[3-methoxy-4-(2-methoxyethoxy)phenyl]-1,2-ethenedithiolato(2-)-S,S']nickel
|
139562-87-1
|
C36H34Cl2NiO6S4-4
|
|
(3aR,4S,7R,7aS)-2-{(1S,2S)-2-[4-(1,2-benzisothiazol-3-yl)piperazin-1-ylMethyl]cyclohexylMethyl}hexahydro-4,7-Methano-2H-isoindole-1,3-dione hydrochloride
|
139563-18-1
|
C28H37ClN4O2S
|
|
(3aR,4R,7S,7aS)-rel-2-[[(1R,2R)-2-[[4-(1,2-Benzisothiazol-3-yl)-1-piperazinyl]methyl]cyclohexyl]methyl]hexahydro-4,7-methano-1H-isoindole-1,3(2H)-dione hydrochloride (1:1)
|
139563-24-9
|
C28H37ClN4O2S
|
|
Lurasidone Impurity 47 HCl
|
139563-25-0
|
C28H37ClN4O2S
|
|
1,2,4,6-TETRA-O-ACETYL-3-O-BENZYL-D-GLUCOPYRANOSE
|
139563-66-9
|
C21H26O10
|
|
N-[2-(5-methoxyindol-3-yl)ethyl]-cyclopropylcarboxamide
|
139564-01-5
|
C15H18N2O2
|
|
(5S)-5-1-Methylethyl-2-Pyrrolidinone
|
139564-41-3
|
C7H13NO
|
|
ETHYL3-ACETOXY-2-METHYLBUTYRATE
|
139564-43-5
|
C9H16O4
|
|
3,5-Octadiyne-2,7-dione (9CI)
|
139565-87-0
|
C8H6O2
|
|
COPPER I / II HEXAFLUOROPENTANEDIONATE - VINYLTRIMETHYLSILANE COMPLEX
|
139566-53-3
|
C10H11CuF6O2Si
|
|
hemoglobin F-Cosenza
|
139568-65-3
|
|
|
|
staufen protein
|
139568-71-1
|
|
|
|
tumor autocrine motility factor receptor
|
139568-77-7
|
|
|
|
luminal binding protein, plant
|
139568-85-7
|
|
|
|
trifucosyl-Lewis-b antigen
|
139568-87-9
|
|
|
|
connective tissue growth factor
|
139568-91-5
|
|
|
|
c10 protein
|
139568-96-0
|
|
|
|
fibril protein, Spiroplasma
|
139569-17-8
|
|
|
LHRH, lysine(6)-glutaryl-2-(hydroxymethyl)anthraquinone
|
139570-70-0
|
C79H98N18O18
|
|
AN152
|
139570-93-7
|
C91H117N19O26
|
|
glutaryl-2-(hydroxymethyl)anthraquinone
|
139571-00-9
|
|
|
Hexitol, 2,5-anhydro-3,4-dideoxy-3-formyl- (9CI)
|
139573-32-3
|
C7H12O4
|
|
Fmoc-Cys(Pam)2-OH (R)
|
139573-77-6
|
C53H83NO8S
|
|
Fmoc-Cys(Pam)2-OH (S)
|
139573-78-7
|
C53H83NO8S
|
|
9H-Purine, 6-chloro-9-[2,3-O-(1-methylethylidene)-5-O-(tetrahydro-2H-pyran-2-yl)-β-D-ribofuranosyl]-
|
139574-39-3
|
C18H23ClN4O5
|
|
Benzenemethanol, 2-[1-(trimethylsilyl)ethyl]- (9CI)
|
139577-13-2
|
C12H20OSi
|
|
Butanoic acid, 2-(acetylamino)-2-ethyl-
|
139578-94-2
|
C8H15NO3
|
|
6-MONOBROMOINDIGO
|
139582-54-0
|
C16H9BrN2O2
|
|
2-Methoxy-6-MethylbenzaMide
|
139583-90-7
|
C9H11NO2
|
|
2-Pyrimidinecarboxylicacid,2-propynylester(9CI)
|
139584-77-3
|
C8H6N2O2
|
|
2-Pyrrolidinecarboximidamide, 1-acetyl- (9CI)
|
139584-79-5
|
C7H13N3O
|
|
N'-AMINOOXYMETHYLCARBONYLHYDRAZINO-D-BIOTIN
|
139585-03-8
|
C12H21N5O4S
|
|
Cyclopentanecarboxylic acid, 3-formyl-, methyl ester, trans- (9CI)
|
139585-46-9
|
C8H12O3
|
|
Cyclopentanecarboxylic acid, 3-(1-propenyl)-, [1alpha,3alpha(E)]- (9CI)
|
139585-47-0
|
C9H14O2
|
|
2-CHLORO-5-METHOXYPYRIDINE
|
139585-48-1
|
C6H6ClNO
|
|
4-CHLORO-2-TRIMETHYLSILYLPYRIDINE
|
139585-50-5
|
C8H12ClNSi
|
|
Pyridine, 5-methoxy-2-(trimethylsilyl)- (9CI)
|
139585-64-1
|
C9H15NOSi
|
|
2-Bromo-5-cyanopyridine
|
139585-70-9
|
C6H3BrN2
|
|
2-Thia-5,7-diazaspiro[3.4]octane(9CI)
|
139585-87-8
|
C5H10N2S
|
|
1-Allyl-2-(trifluoromethyl)benzimidazole
|
139591-03-0
|
C11H9F3N2
|
|
1-(2-PROPYNYL)-2-(TRIFLUOROMETHYL)-1H-1,3-BENZIMIDAZOLE
|
139591-04-1
|
C11H7F3N2
|
|
1-phenyl-2-[2-(trifluoromethyl)-1H-benzimidazol-1-yl]ethanone
|
139591-05-2
|
C16H11F3N2O
|
|
2-Cyclobutene-1-carboxylic acid, 4-(chlorocarbonyl)-, methyl ester, cis- (9CI)
|
139591-41-6
|
C7H7ClO3
|
|
(FMOC-CYS-OTBU)2, (DISULFIDE BOND)
|
139592-37-3
|
C44H48N2O8S2
|
|
3-(hexahydroazepin-1-yl)-1-(3-chloro-4-cyclohexylphenyl)-1-propene hydrochloride
|
139592-99-7
|
C22H32Cl2
|
|
1-((2-chloroethoxy)methyl)-5-fluorouracil
|
139593-08-1
|
C7H8ClFN2O3
|
|
1-((6-chlorohexyloxy)methyl)-5-fluorouracil
|
139593-09-2
|
|
|
1-((2-(2-chloroethoxy)ethoxy)methyl)-5-fluorouracil
|
139593-10-5
|
|
|
5-iodo-6-nitro-2-piperazinylquinoline
|
139593-11-6
|
|
|
amphidinolide F
|
139594-87-9
|
C35H52O9
|
|
viranamycin A
|
139595-03-2
|
C41H64O13
|
|
viranamycin B
|
139595-04-3
|
C44H73NO14
|
|
glutathione iMpurity
|
139595-20-3
|
C10H15N3O5S
|
|
2-Cyclohexene-1-carboxaldehyde, 4-hydroxy-1-methyl-, cis- (9CI)
|
139599-50-1
|
C8H12O2
|
|
2-Cyclohexen-1-ol, 4-methyl-4-(1-propynyl)-, cis- (9CI)
|
139599-54-5
|
C10H14O
|
|
enopeptin A
|
139601-96-0
|
C47H57N7O11
|
|
LOCUSTAKININ I
|
139602-08-7
|
C31H40N8O8
|
|
1-IODO-1-(TRIFLUOROMETHOXY)TETRAFLUOROETHANE
|
139604-89-0
|
C3F7IO
|
|
1-Piperazinecarboxaldehyde,4-(oxiranylmethyl)-(9CI)
|
139605-65-5
|
C8H14N2O2
|
|
1H-Indol-5-ol, 1-(chloroacetyl)-2,3-dihydro- (9CI)
|
139607-68-4
|
C10H10ClNO2
|
|
2-Oxetanone,3-(1-hydroxypropyl)-4-(1-methylethyl)-,[3alpha(R*),4bta]-(9CI)
|
139609-15-7
|
C9H16O3
|
|
SAED
|
139609-20-4
|
C21H22N5NaO10S3
|
|
N1-Hydroxy-N3[(3,4-dimethoxy-6-nitrobenzylidene)amino]guanidine
|
139613-38-0
|
|
|
N1-Hydroxy-N3[(6-bromo-3,4-dimethoxybenzylidene)amino]guanidine tosyla te
|
139613-40-4
|
|
|
4-(PERFLUOROHEXYL)ANILINE
|
139613-90-4
|
C12H6F13N
|